Rejeesh Ramesan Remesh

Rejeesh Ramesan Remesh

Active Director Director DIN 09539248
DIN 09539248 First appointment Mar 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2022
Shareholding value - Across - companies

About Rejeesh Ramesan Remesh

Rejeesh Ramesan Remesh has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ebc Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09539248
Primary Designation Director
First Appointment 23 Mar 2022
Oldest Company Age 6 yrs

Current companies

Company Designation Appointment Founded Status
Ebc Pharmaceuticals Private Limited U24290KL2020PTC061105
Director 23 Mar 2022 2020 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ebc Pharmaceuticals Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Rejeesh Ramesan Remesh

Rejeesh Ramesan Remesh has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ebc Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Rejeesh Ramesan Remesh is associated with 1 company as Director.

Rejeesh Ramesan Remesh has expertise in General Business.

Rejeesh Ramesan Remesh has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available